SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Tvardi Therapeutics Q3 net loss widens 11% to $6.12 million

Tvardi Therapeutics Q3 net loss widens 11% to $6.12 million Tvardi Therapeutics’ third-quarter 2

TVRD

Related stories